Literature DB >> 26139518

Factors associated with clinical failure of self-expandable metal stent for malignant gastroduodenal obstruction.

Young Shin Shin1,2, Cheol Woong Choi2, Dae Hwan Kang2, Hyung Wook Kim2, Su Jin Kim2, Mong Cho2, Sun Hwi Hwang3, Si Hak Lee3.   

Abstract

OBJECTIVE: Endoscopic self-expandable metal stent (SEMS) placement has emerged as an effective palliative treatment for inoperable malignant gastric outlet obstruction (GOO). In spite of successful stent placement, some patients complain of ongoing dysphagia and vomiting. Most reported data on SEMS to date are about technical success of different types of stents and low complication rates. The aim of this study was to evaluate the associated factors of clinical failure after endoscopic SEMS placement for inoperable malignant GOO.
METHODS: A total 122 patients who underwent successful endoscopic SEMS placement for malignant GOO in an academic referral center were included in the analyses. We retrospectively evaluated variables associated with clinical outcomes after successful SEMS placement.
RESULTS: The clinical success rate was 81.1%. The common causes of GOO were pancreatic (39%) and gastric cancers (32%). The mean length of the stents (± standard deviation) was 10.06 ± 2.42 cm. Multivariate analysis revealed that gallbladder cancer (p = 0.016, OR 6.486, 95% CI, 1.509-59.655), poor performance status (ECOG ≥ 3) (p = 0.001, OR 10.200, 95% CI, 2.435-42.721), the presence of carcinomatosis peritonei (p < 0.001, OR 35.714, 95% CI, 5.556-250.000) and the failure of endoscope passage (p = 0.039, OR 6.945, 95% CI, 1.101-43.818).
CONCLUSION: Our results suggest that gallbladder cancer, poor performance status (ECOG ≥ 3) and the presence of carcinomatosis peritonei related with clinical failure of palliative SEMS placement.

Entities:  

Keywords:  gastric outlet obstruction; pancreatic cancer; stent; stomach cancer

Mesh:

Year:  2015        PMID: 26139518     DOI: 10.3109/00365521.2015.1064992

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

Review 1.  Recent advancements in stent therapy in patients with malignant gastroduodenal outlet obstruction.

Authors:  Hironari Kato; Koichiro Tsutsumi; Hiroyuki Okada
Journal:  Ann Transl Med       Date:  2017-04

2.  Covered Metal Stent after Dysfunction of Uncovered Stents for Palliation of Gastrointestinal Malignant Obstruction.

Authors:  Marta Patita; Rui Castro; Diogo Libânio; Rui Pedro Bastos; Rui Silva; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes
Journal:  GE Port J Gastroenterol       Date:  2020-05-13

Review 3.  Efficacy and safety of endoscopic duodenal stent versus endoscopic or surgical gastrojejunostomy to treat malignant gastric outlet obstruction: systematic review and meta-analysis.

Authors:  Rajesh Krishnamoorthi; Shivanand Bomman; Petros Benias; Richard A Kozarek; Joyce A Peetermans; Edmund McMullen; Ornela Gjata; Shayan S Irani
Journal:  Endosc Int Open       Date:  2022-06-10

4.  Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis.

Authors:  Christoph Rademacher; Matthias Bechtler; Steffen Schneider; Bettina Hartmann; Johannes Striegel; Ralf Jakobs
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742

5.  Palliation of malignant gastroduodenal obstruction with self-expandable metal stent using side- and forward-viewing endoscope: Feasibility and outcome.

Authors:  Vinay Kumar; Uday C Ghoshal; Samir Mohindra; Vivek A Saraswat
Journal:  JGH Open       Date:  2018-11-19

Review 6.  How to successfully administer palliative treatment with a stent for malignant gastric outlet obstruction?

Authors:  Iruru Maetani
Journal:  Front Med (Lausanne)       Date:  2022-08-09

7.  Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction.

Authors:  Kentaro Yamao; Masayuki Kitano; Yasutaka Chiba; Takeshi Ogura; Takaaki Eguchi; Ichiro Moriyama; Yukitaka Yamashita; Hironari Kato; Takahisa Kayahara; Noriyuki Hoki; Yoshinobu Okabe; Hideyuki Shiomi; Yoshitaka Nakai; Yoshinori Kushiyama; Yoshifumi Fujimoto; Shiro Hayashi; Shigeki Bamba; Yasushi Kudo; Nobuaki Azemoto; Toshiharu Ueki; Norimitsu Uza; Masanori Asada; Kazuya Matsumoto; Hiroko Nebiki; Hiroshi Takihara; Chisio Noguchi; Hideki Kamada; Kojiro Nakase; Daisuke Goto; Tsuyoshi Sanuki; Tetsuya Koga; Shinichi Hashimoto; Hidefumi Nishikiori; Masahiro Serikawa; Keiji Hanada; Ken Hirao; Masaya Ohana; Imakiire Kazuyuki; Takao Kato; Motoyuki Yoshida; Hirofumi Kawamoto
Journal:  Gut       Date:  2020-11-22       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.